These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7778957

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T, Petermann W, Schürmann D, Bauer TT, Reimnitz P, MOXIRAPID Study Group.
    Clin Infect Dis; 2005 Dec 15; 41(12):1697-705. PubMed ID: 16288390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Community-acquired pneumonia in hospitalized adult patients. Clinical presentation and prognostic factors].
    Saldías F, Mardónez JM, Marchesse M, Viviani P, Farías G, Díaz A.
    Rev Med Chil; 2002 Dec 15; 130(12):1373-82. PubMed ID: 12611238
    [Abstract] [Full Text] [Related]

  • 7. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB, Rhew DC, Wong JY, Charles RA, Goetz MB, American Thoracic Society.
    Arch Intern Med; 2003 Jul 28; 163(14):1718-26. PubMed ID: 12885688
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK, Nopmaneejumruslers C, Chan CK.
    Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ.
    Clin Infect Dis; 2008 Feb 15; 46(4):550-6. PubMed ID: 18194099
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S, Smith S, Newman D, Ritter W, Burke J, Ramirez JA.
    Pharmacotherapy; 1997 Feb 15; 17(3):569-75. PubMed ID: 9165561
    [Abstract] [Full Text] [Related]

  • 19. Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
    Cassiere HA, Fein AM.
    Semin Respir Infect; 1998 Mar 15; 13(1):36-42. PubMed ID: 9543474
    [Abstract] [Full Text] [Related]

  • 20. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar 15; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.